EFFECT OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN ON SERUM CHEMISTRY, HEMATOLOGY, AND LYMPHOCYTE SUBPOPULATIONS - ASSESSMENTS BASED ON CONTROLLED TREATMENT TRIALS IN PATIENTS WITH NEUROLOGICAL DISEASES

Citation
Bm. Koffman et Mc. Dalakas, EFFECT OF HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN ON SERUM CHEMISTRY, HEMATOLOGY, AND LYMPHOCYTE SUBPOPULATIONS - ASSESSMENTS BASED ON CONTROLLED TREATMENT TRIALS IN PATIENTS WITH NEUROLOGICAL DISEASES, Muscle & nerve, 20(9), 1997, pp. 1102-1107
Citations number
34
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
0148639X
Volume
20
Issue
9
Year of publication
1997
Pages
1102 - 1107
Database
ISI
SICI code
0148-639X(1997)20:9<1102:EOHIIO>2.0.ZU;2-Z
Abstract
The effect of intravenous immunoglobulin (IVIG) on various laboratory values was measured immediately before and after completion of serial monthly infusions of IVIG (2 g/kg) or an equal volume of placebo over 3-12 months, in 46 patients with neuromuscular diseases participating in controlled trials. Hematological, lymphocyte subpopulation, and che mistry values were analyzed and compared. After IVIG, but not placebo, a 34% reduction in lymphocytes was noted in 44/46 patients with a sel ective reduction of the T cells, but not the B or IL2R-positive cells. Counts returned to baseline within 30 days. Creatine kinase levels de creased by 23% and sedimentation rate increased by 275% after IVIG inf usion. A nondilutional, artifactual, hyponatremia and hypomagnesemia w as noted with IVIG but not placebo. We conclude that IVIG affects a va riety of serum chemistry and hematological values either directly or a rtifactually by interfering with the laboratory method used for the as says. Transient lymphopenia is consistently seen, and may play a role in the immunomodulating effect of IVIG. (C) 1997 John Wiley & Sons, In c.